AN2 Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel medicines for patients with rare infectious diseases. Co.'s initial product candidate, epetraborole, an antibiotic under development as a once-daily, oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. We show 6 historical shares outstanding datapoints in our ANTX shares outstanding history coverage, used to compute ANTX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ANTX market cap history over the course of time is important for investors
interested in comparing ANTX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ANTX versus a peer is one thing; comparing
ANTX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ANTX can fluctuate over the course of history.
With this page we aim to empower investors researching ANTX by allowing them to research the ANTX market cap history. |
Free ANTX Email Alerts:
Video: The Importance of Market Cap
